Literature DB >> 17993237

Molecular mechanisms of erbB2-mediated breast cancer chemoresistance.

Ming Tan1, Dihua Yu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17993237     DOI： 10.1007/978-0-387-74039-3_9

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  42 in total

1.  B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.

Authors:  Hao Liu; Christina Tekle; Yih-Wen Chen; Alexandr Kristian; Yuhua Zhao; Ming Zhou; Zixing Liu; Yan Ding; Bin Wang; Gunhild Mari Mælandsmo; Jahn Marthin Nesland; Oystein Fodstad; Ming Tan
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

2.  Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.

Authors:  Aurelia Vattai; Elif Akyol; Christina Kuhn; Simone Hofmann; Helene Heidegger; Franz von Koch; Kerstin Hermelink; Rachel Wuerstlein; Nadia Harbeck; Doris Mayr; Christine Spitzweg; Bettina Toth; Sven Mahner; Udo Jeschke; Nina Ditsch
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-13       Impact factor: 4.553

3.  Overcoming trastuzumab resistance in breast cancer by targeting dysregulated glucose metabolism.

Authors:  Yuhua Zhao; Hao Liu; Zixing Liu; Yan Ding; Susan P Ledoux; Glenn L Wilson; Richard Voellmy; Yifeng Lin; Wensheng Lin; Rita Nahta; Bolin Liu; Oystein Fodstad; Jieqing Chen; Yun Wu; Janet E Price; Ming Tan
Journal:  Cancer Res       Date:  2011-04-15       Impact factor: 12.701

4.  miR-31-5p may enhance the efficacy of chemotherapy with Taxol and cisplatin in TNBC.

Authors:  Xiaowei Shen; Jiaqi Lei; Lei Du
Journal:  Exp Ther Med       Date:  2019-11-12       Impact factor: 2.447

Review 5.  Targeting insulin and insulin-like growth factor signaling in breast cancer.

Authors:  Yuzhe Yang; Douglas Yee
Journal:  J Mammary Gland Biol Neoplasia       Date:  2012-10-10       Impact factor: 2.673

6.  Activation of integrin-ERBB2 signaling in undifferentiated thyroid cancer.

Authors:  Xuguang Zhu; Yuelin J Zhu; Dong Wook Kim; Paul Meltzer; Sheue-Yann Cheng
Journal:  Am J Cancer Res       Date:  2014-11-19       Impact factor: 6.166

7.  MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist killer 1 (Bak1) expression.

Authors:  Ming Zhou; Zixing Liu; Yuhua Zhao; Yan Ding; Hao Liu; Yaguang Xi; Wei Xiong; Guiyuan Li; Jianrong Lu; Oystein Fodstad; Adam I Riker; Ming Tan
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

8.  Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression.

Authors:  Kerstin Heselmeyer-Haddad; Lissa Y Berroa Garcia; Amanda Bradley; Clarymar Ortiz-Melendez; Woei-Jyh Lee; Rebecca Christensen; Sheila A Prindiville; Kathleen A Calzone; Peter W Soballe; Yue Hu; Salim A Chowdhury; Russell Schwartz; Alejandro A Schäffer; Thomas Ried
Journal:  Am J Pathol       Date:  2012-10-08       Impact factor: 4.307

9.  Warburg effect in chemosensitivity: targeting lactate dehydrogenase-A re-sensitizes taxol-resistant cancer cells to taxol.

Authors:  Ming Zhou; Yuhua Zhao; Yan Ding; Hao Liu; Zixing Liu; Oystein Fodstad; Adam I Riker; Sushama Kamarajugadda; Jianrong Lu; Laurie B Owen; Susan P Ledoux; Ming Tan
Journal:  Mol Cancer       Date:  2010-02-09       Impact factor: 27.401

10.  Inhibition of autophagy induced by PTEN loss promotes intrinsic breast cancer resistance to trastuzumab therapy.

Authors:  Liao Ning; Zhang Guo-Chun; An Sheng-Li; Li Xue-Rui; Wang Kun; Zu Jian; Ren Chong-Yang; Wen Ling-Zhu; Lv Hai-Tong
Journal:  Tumour Biol       Date:  2015-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.